Emergent BioSolutions
EBS
#8345
Rank
HK$2.44 B
Marketcap
HK$47.51
Share price
3.59%
Change (1 day)
-44.41%
Change (1 year)

EPS for Emergent BioSolutions (EBS)

EPS in 2023 (TTM): -HK$94.69

According to Emergent BioSolutions 's latest financial reports the company's current EPS (TTM) is -HK$26.97. In 2022 the company made an earnings per share (EPS) of -HK$35.12 a decrease over its 2021 EPS that were of HK$33.95.

EPS history for Emergent BioSolutions from 2004 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$94.69169.58%
2022-HK$35.12-203.46%
2021HK$33.95-25.09%
2020HK$45.32445.28%
2019HK$8.31-15.2%
2018HK$9.80-35.9%
2017HK$15.2969.57%
2016HK$9.02-27.67%
2015HK$12.4765.62%
2014HK$7.5311.63%
2013HK$6.7432.31%
2012HK$5.101.56%
2011HK$5.02-60.74%
2010HK$12.7859.8%
2009HK$8.0047.83%
2008HK$5.41-12.66%
2007HK$6.19-35.77%
2006HK$9.6459.76%
2005HK$6.0426.21%
2004HK$4.78

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
HK$5.96-122.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$7.78-128.86%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$22.56-183.64%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
-HK$14.11-47.67%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
HK$4.16-115.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-HK$34.11 26.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$4.94-118.31%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel